Contents
Blockchain for Impact (BFI) Partners with CSIR-CDRI for Biomedical Research and Innovation
BFI Funding for CDRI Research
CDRI to Receive Funding for Upstream Research
Blockchain for Impact (BFI) has recently entered into a partnership with the Council of Scientific & Industrial Research (CSIR)-Central Drug Research Institute (CDRI) to advance biomedical research and innovation through the BFI-BIOME Virtual Network Programme. As part of this collaboration, BFI will be providing financial support to CDRI in Lucknow for a period of three years. This funding will enable CDRI to conduct cutting-edge research in disease biology with the aim of translating these findings into new therapeutic solutions to address emerging healthcare challenges.
Joint Efforts Towards Healthcare Advancements
CSIR-CDRI’s Role in Biomedical Research
The collaboration between BFI and CSIR-CDRI is a significant step towards leveraging the expertise of a leading Indian drug research institute to develop innovative treatments for both communicable and non-communicable diseases. By joining forces with CSIR-CDRI, BFI aims to contribute to national health initiatives and enhance the country’s healthcare capabilities.
The information in the article is for informational purposes only. It does not constitute any investment advice. The author and CryptoBlockNews.com are not responsible for your profits or losses arising from your investments. Investment is ultimately based on many foundations such as knowledge, accumulation, experience, research and personal decisions.
